The Mediterranean diet has long been lauded as the gold standard for heart-healthy eating among experts. But a similar and ...
MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will present new Phase 1 and pre-clinical data on DA-1726, a novel, dual ...
Background: Patients with prior ischemic stroke are at high risk for recurrent stroke and other major adverse cardiovascular events (MACE). The benefits of achieving very low levels of low-density ...
Cashews are generally considered a healthy nut because they’re rich in nutrients that provide numerous health benefits.
When we talk about trending fruits that are also superfoods, amla and avocado often top the discussion. As per Ayurveda, amla ...
Amgen to present new data from cardiovascular portfolio, including late-breaking results from phase 3 VESALIUS-CV trial of Repatha at AHA scientific sessions: Thousand Oaks, Calif ...
Both generic atorvastatin and brand-name Lipitor contain the same active ingredient — atorvastatin calcium — and are considered bioequivalent by the US Food and Drug Administration (FDA). The drug is ...
Explore how pine pollen’s natural phytoandrogens and antioxidants support anabolic health, hormone balance, and vitality in modern naturopathic care.
CARDIO inCode-Score Genetic Risk Influences Cholesterol Risk and Prediction of Coronary Heart Disease IRVINE, CA / ACCESS Newswire / October 28, 2025 / GENinCode, the predictive genetics company ...
Learn how drinking pomegranate juice may benefit heart health and inflammation, and know its medication interactions before sipping.
Live webcasts of the fireside chats will be available through the investor relations section of the NewAmsterdam Pharma website at ir.newamsterdampharma.com. Following the live webcasts, archived ...
Lowering LDL with atorvastatin has been shown to reduce cardiovascular events like heart attacks and strokes after a few years by 22%. When almost 30,000 people in a 2021 study stopped taking their ...